Literature DB >> 35426782

Systematic review of interventions that improve provider compliance to imaging guidelines for prostate cancer.

Samuel M Pettit1, David Mikhail2, Michael Feuerstein3.   

Abstract

INTRODUCTION: Radiographic staging with bone scan or computed tomography is not indicated for men with low-risk prostate cancer. Physician compliance with these imaging recommendations has been widely variable, leading to inappropriate testing and increased costs. The purpose of this systematic review was to identify and learn from interventions associated with improved physician compliance to imaging guidelines for prostate cancer staging.
METHODS: This systematic review followed Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines. PubMed was searched through January 2022 for the following medical subject headings (MeSH) terms: ('practice patterns, physicians' or 'guideline adherence' or 'unnecessary procedures' or 'quality improvement') and ('prostatic neoplasms/diagnostic imaging'). Inclusion required discussion of an intervention for physician compliance to prostate cancer imaging guidelines and specific data describing associated outcomes. Publications focused on other malignancies or without this intervention, evaluation, or data were excluded.
RESULTS: Of 82 papers screened, only five met inclusion criteria - representing 12 802 patients. Each focused on reducing unnecessary imaging and demonstrated statistically significant post-intervention improvement of physician compliance to imaging guidelines for staging prostate cancer. Four were multidimensional, with education, clinical champions, and performance feedback. One used the unidimensional intervention of an electronic medical record (EMR)-based clinical reminder order check (CROC). No studies used randomization or a control group.
CONCLUSIONS: Post-intervention improvement in physician compliance to imaging guidelines for staging prostate cancer has been associated with EMR-based CROC and combination interventions using clinical champions, education, and feedback. This has been observed at individual institutions and larger organizations spanning a region or state.

Entities:  

Year:  2022        PMID: 35426782      PMCID: PMC9484740          DOI: 10.5489/cuaj.7638

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   2.052


  27 in total

1.  Unnecessary imaging for the staging of low-risk prostate cancer is common.

Authors:  Hugh J Lavery; Jonathan S Brajtbord; Adam W Levinson; Fatima Nabizada-Pace; Matthew E Pollard; David B Samadi
Journal:  Urology       Date:  2010-10-08       Impact factor: 2.649

2.  Regional-Level Correlations in Inappropriate Imaging Rates for Prostate and Breast Cancers: Potential Implications for the Choosing Wisely Campaign.

Authors:  Danil V Makarov; Pamela R Soulos; Heather T Gold; James B Yu; Sounok Sen; Joseph S Ross; Cary P Gross
Journal:  JAMA Oncol       Date:  2015-05       Impact factor: 31.777

3.  Bone scan can be spared in asymptomatic prostate cancer patients with PSA of <=20 ng/ml and Gleason score of <=6 at the initial stage of diagnosis.

Authors:  Nobumichi Tanaka; Kiyohide Fujimoto; Takayuki Shinkai; Yasushi Nakai; Masaomi Kuwada; Satoshi Anai; Makito Miyake; Akihide Hirayama; Masatoshi Hasegawa; Yoshihiko Hirao
Journal:  Jpn J Clin Oncol       Date:  2011-08-23       Impact factor: 3.019

4.  A Statewide Intervention Improves Appropriate Imaging in Localized Prostate Cancer.

Authors:  Patrick Hurley; Apoorv Dhir; Yuqing Gao; Brian Drabik; Kenneth Lim; Jon Curry; Paul R Womble; Susan M Linsell; Andrew Brachulis; Donald W Sexton; Khurshid R Ghani; Brian T Denton; David C Miller; James E Montie
Journal:  J Urol       Date:  2016-11-23       Impact factor: 7.450

5.  Do all patients with newly diagnosed prostate cancer need staging radionuclide bone scan? A retrospective study.

Authors:  Mohammed A Al-Ghazo; Ibrahim F Ghalayini; Rami S Al-Azab; Ibrahim Bani-Hani; Alaa Barham; Yazan Haddad
Journal:  Int Braz J Urol       Date:  2010 Nov-Dec       Impact factor: 1.541

6.  Appropriateness of Prostate Cancer Imaging among Veterans in a Delivery System without Incentives for Overutilization.

Authors:  Danil V Makarov; Elaine Y C Hu; Dawn Walter; R Scott Braithwaite; Scott Sherman; Heather T Gold; Xiao-Hua Andrew Zhou; Cary P Gross; Steven B Zeliadt
Journal:  Health Serv Res       Date:  2015-09-30       Impact factor: 3.402

7.  Regional collaboration to improve radiographic staging practices among men with early stage prostate cancer.

Authors:  David C Miller; Daniel S Murtagh; Ronald S Suh; Peter M Knapp; Timothy G Schuster; Rodney L Dunn; James E Montie
Journal:  J Urol       Date:  2011-07-23       Impact factor: 7.450

8.  Bone scanning--who needs it among patients with newly diagnosed prostate cancer?

Authors:  Megumi Hirobe; Atsushi Takahashi; Shin-Ichi Hisasue; Hiroshi Kitamura; Yasuharu Kunishima; Naoya Masumori; Akihiko Iwasawa; Kenji Fujimori; Tadashi Hasegawa; Taiji Tsukamoto
Journal:  Jpn J Clin Oncol       Date:  2007-10-02       Impact factor: 3.019

9.  A qualitative study to understand guideline-discordant use of imaging to stage incident prostate cancer.

Authors:  Danil V Makarov; Erica Sedlander; R Scott Braithwaite; Scott E Sherman; Steven Zeliadt; Cary P Gross; Caitlin Curnyn; Michele Shedlin
Journal:  Implement Sci       Date:  2016-09-02       Impact factor: 7.327

10.  Prospective monitoring of imaging guideline adherence by physicians in a surgical collaborative: comparison of statistical process control methods for detecting outlying performance.

Authors:  Michael Inadomi; Karandeep Singh; Ji Qi; Rodney Dunn; Susan Linsell; Brian Denton; Patrick Hurley; Eduardo Kleer; James Montie; Khurshid R Ghani
Journal:  BMC Med Inform Decis Mak       Date:  2020-05-13       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.